Sartorius Stedim Biotech S.A. Stock Borsa Italiana
Stocks
4DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time Estimate
Tradegate
22:40:46 21/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 202.40 EUR | +2.17% |
|
+5.48% | -5.40% |
| 09-08 | Sartorius Stedim Biotech : Barclays remains its Buy rating | ZD |
| 08-20 | UBS Upgrades Sartorius Stedim Biotech to Buy, Boosts PT | MT |
| Market Cap | 19.61B 22.5B 18.47B 16.82B 31.54B 2,155B 31.58B 221B 85.27B 1,098B 84.5B 82.63B 3,543B | P/E 2026 * |
50.5x | P/E 2027 * | 39.2x |
|---|---|---|---|---|---|
| Enterprise Value | 21.62B 24.8B 20.37B 18.55B 34.77B 2,376B 34.82B 244B 94B 1,210B 93.16B 91.09B 3,906B | EV / Sales 2026 * |
6.92x | EV / Sales 2027 * | 6.16x |
| Free-Float |
28.47% | Yield 2026 * |
0.42% | Yield 2027 * | 0.51% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| DIM | Real-time | |
CBOE
| DIMp | Real-time | |
|
OTC Markets
| SDMHF | Delayed | |
|
Xetra
| 56S1 | Delayed | |
|
Börse Stuttgart
| 56S1 | Delayed | |
|
Tradegate
| 56S1 | Real-time | |
|
CBOE
| 0NK7 | Real-time | |
|
Deutsche Boerse AG
| 56S1 | Delayed | |
|
London S.E.
| 0NK7 | Delayed | |
|
Boerse Muenchen
| 56S1 | Real-time | |
|
Borsa Italiana
| 4DIM | End-of-day quote | |
|
Wiener Boerse
| DIM | End-of-day quote |
Last Transcript: Sartorius Stedim Biotech S.A.
| 1 day | +2.17% | ||
| 1 week | +5.48% | ||
| Current month | +0.81% | ||
| 1 month | +1.59% | ||
| 3 months | +21.31% | ||
| 6 months | +18.48% | ||
| Current year | -5.40% |
| 1 week | 189.1 |  | 198.1 |
| 1 month | 184.4 | | 199.6 |
| Current year | 151.7 | | 222.4 |
| 1 year | 151.7 | | 222.4 |
| 3 years | 146 | | 280.1 |
| 5 years | 146 | | 504 |
| 10 years | 146 | | 504 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 28/03/2023 |
| Chief Tech/Sci/R&D Officer | 61 | 08/09/2011 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 07/04/2015 | |
Susan Dexter
BRD | Director/Board Member | 69 | 07/04/2015 |
Lothar Kappich
BRD | Director/Board Member | 69 | 14/09/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.17% | +5.48% | - | - | 22.1B | |
| +0.32% | 0.00% | -24.54% | +4.20% | 178B | |
| -0.40% | -1.88% | -2.73% | +14.39% | 118B | |
| +1.88% | -3.36% | +9.17% | +70.48% | 58.92B | |
| -0.20% | -1.27% | -3.19% | -31.86% | 49.29B | |
| -0.22% | -0.37% | +10.27% | +42.75% | 48.17B | |
| -0.12% | +5.64% | +28.70% | +0.43% | 33.72B | |
| +0.43% | -2.56% | - | - | 27.76B | |
| -0.10% | +1.70% | +43.22% | -3.49% | 25.5B | |
| +1.77% | +7.87% | +8.39% | -15.89% | 22.1B | |
| Average | +0.53% | +1.65% | +8.66% | +10.13% | 62.32B | |
| Weighted average by Cap. | +0.32% | +0.95% | -2.90% | +12.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.59B 2.94B 2.68B 5.03B 344B 5.03B 35.27B 13.59B 175B 13.47B 13.17B 565B | 3.47B 3.98B 3.27B 2.98B 5.58B 381B 5.59B 39.12B 15.08B 194B 14.94B 14.61B 626B |
| Net income | 381M 437M 359M 327M 613M 41.91B 614M 4.3B 1.66B 21.35B 1.64B 1.61B 68.88B | 483M 554M 455M 414M 777M 53.08B 778M 5.45B 2.1B 27.04B 2.08B 2.04B 87.26B |
| Net Debt | 2.01B 2.3B 1.89B 1.72B 3.23B 221B 3.23B 22.65B 8.73B 112B 8.65B 8.46B 363B | 1.76B 2.01B 1.65B 1.51B 2.82B 193B 2.83B 19.8B 7.63B 98.26B 7.56B 7.4B 317B |
| Date | Price | Change |
|---|---|---|
| 18/09/26 | €198.10 | +0.51% |
| 21/09/26 | €202.20 | +2.07% |
| 18/09/26 | €198.10 | +0.51% |
| 17/09/26 | €197.10 | +1.34% |
| 16/09/26 | €194.50 | +2.86% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
- 4DIM Stock
Select your edition
All financial news and data tailored to specific country editions
